[ad_1]
DUBLIN, Sept. 30, 2022 /PRNewswire/ — The “Global Nephrotic Syndrome Diagnostics & Therapeutics Market Forecast, 2022-2028” report has been added to ResearchAndMarkets.com’s offering.
The global nephrotic syndrome diagnostics & therapeutics market is anticipated to grow at a CAGR of 5.6% during the forecast period. Nephrotic syndrome is a kidney disease in which the body excretes an excessive amount of protein in the urine. Damage to the clusters of tiny blood vessels in kidneys that remove waste and excess water from blood is the most common cause of the nephrotic syndrome.
Diabetes, which can cause diabetic nephropathy and thus affect glomeruli, has been one of the major factors driving the market growth during the forecast period. The other factors being the increasing rate of hyperlipidemia, the rise of complications, such as thromboembolism, HIV, hepatitis B, and hepatitis C, also contribute to the rising rate of nephrotic syndrome incidence and prevalence across the globe will further driving …
Full story available on Benzinga.com
[ad_2]
Source link
